Take supplements that naturally increase GLP-1
Insurance coverage for weight management with GLP-1s is inconsistent
Recent Findings Beyond weight reduction, GLP-1RAs have shown positive cardiovascular outcomes in patients with elevated ASCVD risk, heart failure with preserved ejection fraction, obstructive sleep apnea, blood pressure, and dyslipidemia
Obesity research consistently shows that the biological changes driving weight regain persist long after weight is lost
They target multiple disease pathways at once: metabolic dysfunction, cardiovascular disease, inflammation, neurodegeneration, kidney decline, and even some cancers
The motivations differ sharply by gender